Komori
Tokuyama (4043) · InitiativeAdvanced

Business Portfolio Review

First written in FY2016. 9 of 14 entries say "Advanced", first in FY2021-Q2. Latest entry: 2026-10-01.

14entries
11years
5from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseCited as achievedFY2017-Q3AdvancedFY2021-Q2 – 2026-10-012016: 220162017: 120172018: 020182019: 020192020: 120202021: 120212022: 020222023: 220232024: 020242025: 120252026: 62026
Same theme, other companies
Portfolio restructuring through concentration on priority businesses and exit from non-priority businessesA theme 16 companies write about · 0 as a headwind · 16 as a tailwind

The whole theme swung hardest in 2018: 1 of 7 companies on the "Worse" side.

9 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 16 companies compared. The sentences above are computed from all 16.
Full recordFilings, disclosures and news, newest first
  1. 2026-10-01AdvancedOccurring Fact

    「Transfer of all shares held by the company to TAIHEIYO CEMENT CORPORATION」

    The company executed the transfer of the domestic cement and solidifying-materials sales business and other operations, advancing the selective concentration of its existing businesses as part of its business portfolio review.
  2. FY2026AdvancedAnnual report

    「Meanwhile, the company completed its withdrawal from the manufacturing and sales business for microporous films in China in February 2026.」

    Following the earlier review of フィガロ技研株式会社 and other businesses, the company completed its withdrawal from the microporous film business in China, advancing the selection and concentration of its portfolio.
  3. FY2026-H1AchievedAnnual report

    「At a meeting of the Board of Directors dated 22 April 2025, the company resolved to acquire all shares of a new company established by JSR株式会社 and make it a subsidiary, entered into a share transfer agreement on the same date, and acquired the shares on 1 October 2025.」

    The acquisition of all shares in the new company established by JSR株式会社 was completed on 1 October 2025, making the in-vitro diagnostic products business and other operations subsidiaries. The expansion of the business portfolio into Healthcare moved into the execution phase.
  4. FY2024-Q2AdvancedAnnual report

    「As the company sold part of its holdings in 株式会社エクセルシャノン, which had been a consolidated subsidiary through the previous consolidated fiscal year, it was excluded from the scope of consolidation and included in the scope of application of the equity method from the second-quarter consolidated accounting period.」

    The partial sale of shares in 株式会社エクセルシャノン moved it from consolidated subsidiary status to an equity-method affiliate, advancing the review of the business portfolio.
  5. FY2023-Q3AdvancedAnnual report

    「As the company acquired shares in 株式会社スーパーナノデザイン, the subsidiary has been included in the scope of consolidation from the current third-quarter consolidated accounting period.」

    The acquisition of shares in 株式会社スーパーナノデザイン made it a consolidated subsidiary from the current third-quarter consolidated accounting period. A specific acquisition expanding the business portfolio was added.
  6. FY2021-Q3AchievedAnnual report

    「As the company sold part of its holdings in サン・トックス株式会社 on 1 October 2020, the company was excluded from the scope of consolidation and included in the scope of application of the equity method from the current third-quarter consolidated accounting period. Effective date of the share exchange 1 February 2021」

    As part of the review of the business portfolio, the company sold part of its holdings in サン・トックス株式会社 and made it an equity-method affiliate. In addition, the share exchange with エイアンドティー decided in the previous quarter was executed on 1 February 2021, moving the strengthening of the healthcare business and portfolio reform into the execution phase.
  7. FY2021-Q2AdvancedAnnual report

    「At a meeting of the Board of Directors held on 28 October 2020, the company resolved to carry out a share exchange effective 1 February 2021, under which the company would become the wholly owning parent company and 株式会社エイアンドティー (hereinafter, エイアンドティー) the wholly owned subsidiary, and entered into the share exchange agreement on the same date.」

    The company decided to make エイアンドティー a wholly owned subsidiary through a share exchange, strengthening the healthcare business in the Life Amenity segment and advancing portfolio reform in line with the shift toward decarbonization. The effective date was scheduled for 1 February 2021, with an exchange ratio of 0.68 Tokuyama shares for each エイアンドティー share and 2,543,952 shares scheduled to be issued.
  8. FY2017-Q3Cited as achievedAnnual report

    「As the company sold part of its holdings in フィガロ技研株式会社, which had been a consolidated subsidiary, the company was excluded from the scope of consolidation and included in the scope of application of the equity method from the second-quarter consolidated accounting period.」

    The partial sale of shares in フィガロ技研株式会社, followed by its removal from consolidation and inclusion under the equity method from the second quarter, reconfirmed the completed review of the business portfolio.
  9. FY2017-Q1AchievedAnnual report

    「We transferred part of our holdings in フィガロ技研株式会社, a wholly owned subsidiary, to NEW COSMOS ELECTRIC CO.,LTD.」

    On 1 July 2016, 64,602 shares were transferred for ¥4,329 million, executing a review of the business portfolio that would result in an ownership ratio of 33.4% after the transfer.
  10. FY2016First statedAnnual report

    「We decided to transfer part of our holdings in フィガロ技研株式会社, a wholly owned subsidiary, to NEW COSMOS ELECTRIC CO.,LTD.」

    The company planned to transfer 64,602 shares for ¥4,329 million on 1 July 2016, reducing its ownership ratio to 33.4% after the transfer. The stated reason was a review of the business portfolio.
Moved together

"Shift to a Customer-Focused Approach and Expansion into New Areas" moved the same way as this thread, in the same document, in 7 of its 14 moves.

766544★123456
  1. ★This thread
  2. 1Shift to a Customer-Focused Approach and Expansion into New Areas7×
  3. 2Strengthening Business Earnings Power6×
  4. 3Rebuilding the financial base and restoring shareholders’ equity6×
  5. 4No dividends while prioritizing financial soundness, with an early resumption of dividends5×
  6. 5Raw Material and Fuel Market Conditions and Procurement Risk4×
  7. 6Investment to Expand Growth Businesses and Strengthen the Competitiveness of Traditional Businesses4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Tokuyama's next results are scheduled for 2026-10-29. Read the earnings preview It last moved in the Occurring Fact of 2026-10-01: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Business Portfolio Review | Tokuyama Corporation (4043) | Komori